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Objective: To identify the causative gene in spinocerebellar ataxia (SCA) 22, an autosomal dominant cerebellar
ataxia mapped to chromosome 1p21-q23.
Methods: We previously characterized a large Chinese family with progressive ataxia designated SCA22, which overlaps with
the locus of SCA19. The disease locus in a French family and an Ashkenazi Jewish American family was also mapped to this
region. Members from all 3 families were enrolled. Whole exome sequencing was performed to identify candidate mutations,
which were narrowed by linkage analysis and confirmed by Sanger sequencing and cosegregation analyses. Mutational analyses
were also performed in 105 Chinese and 55 Japanese families with cerebellar ataxia. Mutant gene products were examined in a
heterologous expression system to address the changes in protein localization and electrophysiological functions.
Results: We identified heterozygous mutations in the voltage-gated potassium channel Kv4.3-encoding gene
KCND3: an in-frame 3-nucleotide deletion c.679_681delTTC p.F227del in both the Chinese and French pedigrees,
and a missense mutation c.1034G>T p.G345V in the Ashkenazi Jewish family. Direct sequencing of KCND3 further
identified 3 mutations, c.1034G>T p.G345V, c.1013T>C p.V338E, and c.1130C>T p.T377M, in 3 Japanese kindreds.
Immunofluorescence analyses revealed that the mutant p.F227del Kv4.3 subunits were retained in the cytoplasm,
consistent with the lack of A-type Kþ channel conductance in whole cell patch-clamp recordings.
Interpretation: Our data identify the cause of SCA19/22 in patients of diverse ethnic origins as mutations in KCND3.
These findings further emphasize the important role of ion channels as key regulators of neuronal excitability in the
pathogenesis of cerebellar degeneration.
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Spinocerebellar ataxia (SCA) is a clinically, pathologi-cally, and genetically heterogeneous group of domi-
nantly inherited neurodegenerative disorders characterized
by progressive cerebellar ataxia variably associated with
pyramidal, extrapyramidal, bulbar, spinal, and peripheral
nervous system involvement. Thirty-two dominant SCAs
(labeled SCA1–36) have been chromosomally mapped,
and the genes causing 20 of these disorders have so far
been identified.1,2 The genetic etiologies of many SCAs
have yet to be elucidated.3,4
Previously, we characterized a large Chinese pedi-
gree with an autosomal dominant ataxia spanning 4 gen-
erations.5 The disease locus was mapped to chromosome
1p21-q23 and was designated SCA22.5 The locus of
SCA22 overlaps with that of SCA19 on 1p21-q21, previ-
ously identified in a Dutch family.6,7 SCA19 and SCA22
were therefore proposed to be allelic with a worldwide
distribution.7 Here, we report mutations in KCND3 in
the original SCA22 family as well as in 5 other SCA




In family A of Han Chinese origin (Fig 1A), the original
SCA22 family, we enrolled 31 members, including 13 affected,
6 unaffected, 6 at-risk, and 6 married-in individuals. The age at
onset of ataxia in this pedigree ranged from 13 to 46 years.
Clinical severity of ataxia was evaluated longitudinally using the
40-point (0 being normal) validated Scale for the Assessment
and Rating of Ataxia (SARA).8,9
In family B, of French origin (see Fig 1B), including 8
affected individuals, 4 at-risk relatives, and 1 spouse partici-
pated in the study. Age at onset ranged from 24 to 51 years.
Pathological nucleotide expansions were excluded in SCA1, 2,
Machado–Joseph disease/SCA3, 6, 7, 10, 12, 17, 31, 36 and
ATXN1 genes, as were mutations in (SCA5, 11, 13, 14, 23,
and 28 genes).
Family C, of Ashkenazi Jewish American origin (see Fig
1C), was ascertained through a proband (III-3) with ataxia with
onset in her 50s. Samples from her and an affected relative
were negative by commercial DNA testing, excluding SCA1, 2,
3, 5, 6, 7, 8, 10, 13, 14, and 17 and DRPLA (Athena Diagnos-
tics, Worcester, MA). Four affected and 3 unaffected subjects
(including 1 apparently unaffected obligate carrier), along with
2 spouses participated in the study.
In addition, we screened for mutations in the candidate
gene in DNA from the index patients of 105 Chinese and 55
unrelated Japanese families with cerebellar ataxia, in whom
mutations in SCA1, SCA2, Machado–Joseph disease/SCA3,
SCA6, SCA7, SCA8, SCA12, SCA17, SCA31, and ATXN1
genes had been excluded.
Written informed consent was obtained from all subjects
according to study protocols approved by the institutional
review boards of Taipei Veterans General Hospital, the Paris-
Necker Ethics Committee, University of Michigan, and Univer-
sity of Tokyo. Genomic DNA was isolated from peripheral
blood leukocytes following a standard protocol.10
Genetic Studies
Linkage Analysis. (Linkage analysis in family A to
1p21-q23 has been previously reported.5) In families B
and C, genome scans were performed using Illumina
(San Diego, CA) LINKAGE_12 microarrays (6,090 single
nucleotide polymorphism [SNP] markers). Genotypes were
determined using Beadstudio (Illumina) and analyzed with
MERLIN 1.0.11
In family B, linkage analysis was run under a 0.85 pene-
trance model with equal allele frequencies, similar recombina-
tion fractions between males and females, and a disease fre-
quency of 0.0005.
In family C, linkage analysis (run with 0.85 penetrance
due to the presence of an unaffected obligate carrier female in
the pedigree) identified 200Mb regions on 8 different chro-
mosomes with LOD scores between 0 and 2.0, reaching maxi-
mal LOD score of 1.97 on chromosome 1. To further narrow
the regions, DNA of the most distantly related affected subjects
(IV-6 and IV-7; see Fig 1C) was hybridized to Illumina
Human660W-Quad high-density SNP BeadChips. PLINK12
was used to identify chromosomal regions with large
(>1,000kb) shared haplotypes.
(EXOME SEQUENCING.) Exomes were captured and
enriched using either the Agilent SureSelect Human All Exon
50Mb kit (Agilent Technologies, Santa Clara, CA; families A
and B) or the Nimblegen SeqCap EZ v1 (Roche, Indianapolis,
IN; family C). The enriched samples were sequenced on the
Illumina HiSeq2000 (Illumina) platform.
In families A and C, 2 affected subjects were sequenced,
whereas in family B, DNA from 1 affected subject (III-6), the
married-in parent (II-7), and 1 unaffected control subject were
sequenced (see Fig 1). Only variants in the linked region and
shared by both affected subjects sequenced (families A and C)
or absent from the 2 controls (family B) were considered. Var-
iants present in dbSNP, the 1000 Genomes Project,13 the
exome variant server (http://evs.gs.washington.edu/EVS/), or
previously sequenced individuals without SCA were excluded.
Variants were further filtered for those predicted to be function-
ally damaging, that is, nonsynonymous and splice variants. The
details of exome sequencing, variants filtering, and analyses are
available in the Supporting information.
Molecular analyses of KCND3
Mutational analysis of exons and their flanking introns of
KCND3 was conducted by polymerase chain reaction followed
by direct nucleotide sequence analysis as previously described.14
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FIGURE 1: Pedigree charts of the families A, B, C, D, E, and F. The gender of the family members is obscured for privacy. The
proband is denoted by an arrow. Filled diamonds represent affected members, grayed diamonds represent members with in-
formation suggesting but not confirming spinocerebellar ataxia, open diamonds indicate unaffected individuals, and those
with a dot within an open diamond denote at-risk individuals. / 5 deceased; * 5 members who underwent whole exome
sequencing; # 5 individuals included in linkage analysis; 1 5 wild-type allele; del 5 allele with F227del; V 5 allele with
G345V; E 5 allele with V338E; M 5 allele with T377M.
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Expression Plasmids
A human Kv4.3 expression clone pE-11.GFPIre.hKv4.3L.WT
was a generous gift of Dr J. M. Nerbonne (Washington Univer-
sity, St. Louis, MO).15,16 The coding region of KCND3 was
subcloned into the pFLAG-CMV-5a vector (Sigma-Aldrich, St
Louis, MO). The mutation c.679_681delTTC was introduced
by site-directed mutagenesis using the Quick-Change method
(Stratagene, Santa Clara, CA) and verified by bidirectional
sequencing. The human Kv channel interacting protein 2
(KChIP2) expression clone was purchased from Open Biosys-
tems (Thermo Scientific, Lafayette, CO). We constructed a
plasmid expressing the integral membrane protein myelin pro-
tein zero (P0) fused to DsRed to mark the cell surface as previ-
ously described.17 The endoplasmic reticulum (ER) markerp-
DesRed-ER was purchased from Clontech (Mountain View,
CA). All constructs were verified by sequencing.
Cell Culture and Transfection
Human embryonic kidney (HEK)-293T cells were maintained
in high glucose Dulbecco modified Eagle medium supple-
mented with 10% fetal bovine serum (FBS) in a humidified in-
cubator at 37C under 5% CO2. Cells were grown on glass
coverslips in 6-well multiwell plates. Transient transfection was
performed using the calcium phosphate precipitation method.18
HEK293T cells were transiently transfected with plasmids (in
1:1:1 ratio, 200ng each) expressing Kv4.3 (either wild-type
[WT] or the F227del mutant), KChIP2, and either P0-DsRed
(to mark the cell surface) or DsRed-ER (to mark the ER).
Immunofluorescence Staining
Forty-eight hours after transfection, cells were fixed in 4% para-
formaldehyde for 30 minutes, permeabilized with 0.2% Tween-
20 for 30 minutes, and blocked with 1% bovine serum albu-
min for 30 minutes before incubation in primary antibody
mouse anti-Kv4.3 at a dilution of 1:1,000 (ab99045; Abcam,
Cambridge, UK) overnight at 4C. Bound primary antibodies
were detected using Alexa 488-conjugated goat antimouse im-
munoglobulin G (a11001; Invitrogen, Grand Island, NY).
Confocal Imaging
Images were captured with a Zeiss (Thornwood, NY) LSM 5 Pascal
Laser Scanning Confocal system mounted on an Axiovert 200M
inverted fluorescence microscope with a 63 oil immersion objec-
tive. Confocal imaging was performed on expression studies from 6
independent transfections. All images were processed and analyzed
using ImageJ (National Institutes of Health, Bethesda, MD).
The midlevel optical section was selected for quantifica-
tion of the surface expression of Kv4.3, with P0 staining to
define the plasma membrane. A blank region was selected to
calculate the average pixel intensity as the background, which
was subtracted from all images. In the channel of the cell sur-
face marker P0 signal, 20% of the maximum pixel intensity
was set as the threshold to define the cell contour. Surface
expression of Kv4.3 was calculated as the amount of Kv4.3 sig-
nal in the plasma membrane region normalized by the total sig-
nal intensity inside the cell contour.
Electrophysiological Recordings
HEK-293T cells were transfected with either WT or p.F227del
Kv4.3 cloned into a Green fluorescence protein plasmid
(pGFP) Ire vector, together with KChIP2 in a 1:1 ratio. Cells
transfected with the vectors alone plus KChIP2 were used as
controls. GFP-positive HEK-293T cells were used for electro-
physiological recordings 48 hours after transfection. HEK cells
were transferred to bath solution containing (in millimolars)
NaCl 150, KCl 5, MgCl2 1, CaCl2 2.2, N-2-hydroxyethylpi-
perazine-N0-2-ethanesulfonic acid (HEPES) 10, and glucose 5;
pH was adjusted to 7.3 with HCl. Transfected cells were visu-
ally selected by green fluorescence expression for recording
under bright-field optics (BX51WI; Olympus, Tokyo, Japan).
Patch pipettes (2–5MX) were pulled from borosilicate glass
capillaries (outer diameter, 1.5mm; inner diameter, 0.86mm;
Harvard Apparatus, Holliston, MA), heat-polished, and then
filled with internal solution containing (in millimolars) K-glu-
conate 120, KCl 24, ethyleneglycoltetraacetic acid 0.2, and
HEPES 10; pH was adjusted to 7.3 with KOH. Using a Multi-
clamp 700B amplifier (Molecular Devices, Union City, CA),
whole cell patch recordings were made at 22 to 24C. Pipette
capacitance was compensated in cell-attached configuration, and
patched cells were held in the voltage-clamp configuration at
90mV with series resistance (RS) compensation (80–90%,
lag, 0.5 milliseconds; RS before compensation, 10–25MX).
Potassium currents were evoked by voltage pulses (80 to
þ70mV, 500 milliseconds; 10mV increments). Leakage and
capacitive currents were subtracted using a P over 4 proce-
dure. Membrane capacitances were determined from readout
values (6–60pF) of membrane capacitance compensation on the
patch amplifier. Potassium equilibrium potential (86mV) was
determined by the Nernst equation. Signals were low-pass fil-
tered at 4kHz (4-pole Bessel) and sampled at 10kHz using the
Digidata 1440 interface (Molecular Devices). Data acquisition
was performed using the pClamp 10.2 software (Molecular
Devices).
Results
Linkage Identifies SCA19/22 on 1p21-q23 as a
Common Dominant Ataxia Locus
Families B and C with dominant adult onset ataxia were
ascertained in France and in the USA in efforts to iden-
tify novel ataxia loci. Genome-wide low-density SNP
chips followed by linkage analysis were used to identify
candidate chromosomal regions. In family B, putative or
uninformative linkage to 11 candidate regions was con-
sidered, including 6 regions reaching the maximal
expected value of LOD score of 2.8 according to the
pedigree structure (chromosomes 1, 2, 8, 9, and 14). In
family C, high-density SNP chips and PLINK were used
to identify shared haplotypes between the most distant
relatives. Only 2 large shared haplotypes matched the
linkage peaks, a 62Mb-long haplotype on chromosome 1
and a 33Mb haplotype on chromosome 15. The shared
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haplotype with the highest LOD score on chromosome 1
overlapped the SCA22 region.
Exome Sequencing Identifies KCND3 Mutations
in Families with Dominant Ataxia
In family A, after analysis and filtering, 11 heterozygous
coding variants that mapped to 1p21-q23 were shared by
both affected subjects and were not present in thousands
of control samples in various databases (Supplementary
Table 1). Sanger sequencing of these variants in the
remaining 23 family members identified only 1 variant,
c.679_681delTTC in KCND3, that completely segre-
gated with the disease phenotype (Fig 2A). This muta-
tion was not found in 500 normal Taiwanese-Chinese
controls.
In family B, of 1,648 nucleotide variants present in
the affected subject but absent in her married-in parent
and the control, only 3 variants were heterozygous,
absent, or rare in the Exome Variant Server and pre-
dicted to be damaging (Supplementary Table 2). Among
these variants, c.679_681delTTC p.F227del in KCND3
(see Fig 2B) was the strongest candidate, because muta-
tions in the 2 other genes were known to have non-neu-
rological phenotypes (detailed in the Supporting Infor-
mation). This mutation cosegregated with the disease in
the family and was absent from 152 French control chro-
mosomes and in public database.
In family C, exome sequencing identified a large
number of shared variants between the 2 affected indi-
viduals. After filtering by linkage and shared haplotypes,
variants and that were predicted to be damaging, only 1
passed all filters, c.1304G>T p.G345V in KCND3 (see
Fig 2C; Supplementary Table 3). Conventional sequenc-
ing confirmed segregation in the family.
Mutation Screening in Chinese and Japanese
Families with Hereditary Spinocerebellar
Ataxias
No mutation in KCND3 was found from any index
patient of 105 Chinese families with hereditary ataxia.
Three missense mutations in KCND3 were identi-
fied in 3 families among 55 Japanese families with ataxia
(see Fig 1D): c.1013T>C p.V338E in exon 1 was found
in family D, c.1034G>T p.G345V in exon 1 in family
E, and c.1130C>T p.T377M in exon 2 in family F.
None of these mutations was present in 96 Japanese con-
trols or public databases.
SCA22-Associated Mutations Alter
Highly Conserved Amino Acid Residues
All of the ataxia-associated mutations affect amino acids in
Kv4.3 that are highly conserved across a wide variety of
species, from zebrafish, frog, platypus, and mouse to
humans (see Fig 2E). In silico analysis predicted deleterious
consequences from the residue changes (Supplementary 4).
Clinical Features of Patients with KCND3
Mutations
Characteristically, the patients in the families with
SCA19/22 all have a very slowly progressive cerebellar
ataxia. In family A (Supplementary Table 5), II-3 has
had difficulty walking for 35 years, with an onset at 46
years, and still manages to ride a 3-wheel motorcycle.
III-2, at the age of 57 years (25 years after the onset of
disease), has had a very slow progression of ataxia, with
an average deterioration of only 0.3 SARA score point
per year over the past 5 years. III-8 has been mildly
ataxic for 31 years and yet only has a SARA score of 9
points at the age of 48 years. There has been no cogni-
tive impairment, myoclonus, tremors, focal weakness,
sensory loss, cogwheel rigidity, visual impairment, reti-
nopathy, or ophthalmoplegia in any of the affected mem-
bers. Brain magnetic resonance imaging (MRI) featured
mild cerebellar atrophy (Supplementary Fig, A). Their
electrocardiograms showed sinus rhythm with normal
QT intervals. There was no arrhythmia on the 24-hour
Holter monitor recordings. The echocardiograms were
also unremarkable.
In family B (Supplementary Table 6), age at onset
ranged between 24 and 51 years, and most patients have
been seen at least twice to evaluate disease evolution.
Progression was slow, as reflected by only 1 wheelchair
user after 43 years of disease duration. Cerebellar ataxia
was associated with impaired vibration sense at the ankles
(3 of 8), with upward ophthalmoplegia (1 of 8) or with
diplopia (1 of 8). Hyper-reflexes without positive Babin-
ski sign was present in 3 of 8. Mild cogwheel rigidity
was noticed in 2 patients at ages 61 and 77 years. In the
absence of pyramidal involvement, urinary urgency/
incontinence was seen in 5 of 8. Cerebellar atrophy was
present in 5 patients with cerebral MRI (Supplementary
Fig, B). The index case had sensory neuropathy.
In family C, the proband (III-3) is tripping and
falling slightly more frequently now (once or twice each
month), 10 years after the beginning of imbalance and
slurred speech at the age of 55 years, which have only
slightly progressed in the absence of any visual problem
or dysphagia. Neurological examination revealed break-
down of the smooth pursuit with saccades, mild dysarth-
ria, difficulty with heel-to-shin test, mildly wide-based
gait, and difficulty with tandem walk. One of the 4 chil-
dren, 1 of the siblings, and 1 of the first cousins also
have had imbalance (Supplementary Table 7). Brain MRI
revealed cerebellar vermian atrophy.
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FIGURE 2: KCND3 mutations and Kv4.3 membrane topology. (A–D) The electropherograms of KCND3 heterozygous muta-
tions. (E) Predicted Kv4.3 topology and locations of 4 mutations: red triangle, c.679_681delTTC (p.F227del); blue circles,
c.1013T>C p.V338E, c.1034G>T p.G345V, and c.1130C>T p.T377M. The mutated residues are evolutionarily conserved, as
shown by aligning protein sequences of Kv4.3 orthologs in various organisms.
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In families D, E, and F, the age at onset was late,
and the clinical progression of ataxia was also slow in the
majority of the affected (Supplementary 8).
Immunofluorescence Studies
The immunofluorescence staining pattern of HEK-293T
cells expressing either WT or p.F227del mutant Kv4.3
was characterized to address the question of channel pro-
tein localization. Cells expressing WT Kv4.3 displayed
robust cell surface Kv4.3-specific staining, whereas virtu-
ally all cells expressing the mutant Kv4.3 demonstrated
diffuse cytoplasmic Kv4.3-specific staining without dis-
cernible cell surface signal, suggesting impaired plasma
membrane targeting of the mutant F227del Kv4.3 pro-
tein, which appeared to be abnormally retained in the
cytoplasm and colocalized with an ER-specific marker
(Fig 3). We observed no evidence of Kv4.3 in the mock-
transfected cells. The expression of the cell surface
marker P0 enabled us to define the cell membrane and
quantify the subcellular localization of Kv4.3 using an
unbiased approach. The ratio of cell surface expression
for the p.F227del Kv4.3 was significantly lower than that
observed in the WT Kv4.3 (n ¼ 10; mean 6 standard
error of the mean, 0.28 6 0.04 vs 0.61 6 0.06; p ¼
0.0014).
Electrophysiological Recordings
In whole cell voltage-clamp recording on transfected
HEK-293T cells, potassium currents were evoked by
voltage pulses. In the control cells (KChIP2 þ GFP),
HEK-293T cells exhibited endogenous noninactivating
outward currents (Fig 4). In contrast, large transient out-
ward currents were observed in the WT Kv4.3-trans-
fected HEK293T cells (WT Kv4.3 þ KChIP2 þ GFP).
The outward currents recorded from p.F227del Kv4.3-
transfected HEK293T cells (p.F227del þ KChIP2 þ
GFP) were comparable to the endogenous potassium
currents recorded from mock-transfected cells. After nor-
malizing the current amplitude for cell size, WT Kv4.3-
transfected cells had a significantly higher current density
compared to p.F227del-transfected cells (WT: 0.52 6
0.14 Nano-Ampere/pico-Faraday (nA/pF), n ¼ 8;
p.F227del: 0.09 6 0.02 nA/pF, n ¼ 7; p < 0.0005,
Mann–Whitney test). The difference in current densities
between p.F227del-transfected and control cells
(p.F227del: 0.09 6 0.02 nA/pF, n ¼ 17; control: 0.09
6 0.01 nA/pF, n ¼ 3; p ¼ 0.67, Mann–Whitney test)
was not statistically significant. Given that the cell surface
expression level of p.F227del Kv4.3 was minimal, the
finding of low current densities by electrophysiological
recordings is consistent with a notion of a defect in chan-
nel expression.
Discussions
Using exome sequencing and mutational analyses, we
identified in 6 unrelated families of diverse ethnic origins
with autosomal dominant cerebellar ataxia heterozygous
mutations in the voltage-gated potassium channel Kv4.3-
encoding KCND3 gene. A 3-nucleotide in-frame deletion
leading to p.F227del cosegregated with ataxia in family
A of Han Chinese origin and family B of French origin.
A missense mutation leading to p.G345V was found in
family C of Ashkenazi Jewish origin and family E of Jap-
anese origin. Two other missense mutations leading to
p.V338E and p.T377M were identified in 2 other Japa-
nese families. All of the amino acids involved are evolu-
tionarily conserved in all vertebrates. The mutations were
not observed in the Exome Variant Server, 10 Chinese
and 32 French non-SCA subjects, or 1,248 chromosomes
of French, Chinese, or Japanese controls. Our findings
provide strong genetic support for KCND3 being the
causative gene in SCA19/22.
Kv4.3 is highly expressed in the brain, in particular
in the cerebellar Purkinje cells, granule cells, basket cells,
stellate cells, a subset of c-aminobutyric acidergic deep
neurons, and Lugaro cells adjacent to the somata of Pur-
kinje cells.19–23 Kv4.3 may play an important role in the
development of cerebellum.23,24 Of note, Kv4.3 is also
expressed in the heart, and rare missense mutations in
the cytoplasmic C-terminus have been implicated in Bru-
gada syndrome,25 which is a hereditary condition with
cardiac arrhythmia predisposed to sudden cardiac death.
There was no mention of neurological disorders in these
patients. None of the patients in this report had cardiac
symptoms or signs.
KCND3 encodes Kv4.3, an alpha subunit of the Shal
family of the A-type voltage-gated Kþ channels which are
important in membrane repolarization19 in excitable cells.
Similar to other voltage-gated Kþ channels, Kv4.3 forms
homo- or heterotetramers with members of the Shal sub-
family channels. Each alpha subunit has 6 transmembrane
segments (S1–S6) and a re-entrant loop linking S5 and S6
(see Fig 2D). S1 through S4 form the voltage sensing do-
main, whereas S5, S6, and the re-entrant loop form the ion
selective pore. F227 resides in S2 and is conserved between
Kv4 and Kv1 of the Shaker family, which, similar to Shal,
also carries a voltage-dependent potassium current. F227 is
equivalent to F223 in Kv1.2 and F280 in Shaker. Function-
ally, F227 has been suggested to be a high-impact residue
that indirectly coordinates the omega pathway, which is
formed by S1–S3 helices and S4 movement in response to
membrane voltage changes.26,27 Thus, p.F227del may lead
to a shift in the downstream residues in S2 lining the ion
permeation pathway to interfere with the normal movement
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of S4. Empirically, we were surprised not to be able to detect
any channel activity or changes in the biophysical properties
of the channel (see Fig 4). Instead, we observed intracellular
retention, suggesting that p.F227del causes a loss of channel
function by interfering with proper plasma membrane tar-
geting and incorporation into a functional tetrameric chan-
nel complex (see Fig 3).
V338 resides in S5, and both G345 and T377 are
in the putative outer vestibule of the channel between
transmembrane segments S5 and S6. Efforts are under-
way to continue to characterize the functional consequen-
ces of mutations in KCND3.
Following KCNA1 (Kv1.1, NM_000217) and
KCNC3 (Kv3.3, NM_004977), KCND3 (Kv4.3,
FIGURE 3: Confocal images demonstrating impaired cell surface expression and cytoplasmic retention of the mutant F227del
Kv4.3. HEK-293T cells were transiently transfected with wild-type (WT; A) or p.F227del mutant (B) human Kv4.3, or empty vec-
tor (C) and immunostained with Kv4.3-specific antibody and green fluorophore-labeled secondary antibodies. Green fluoro-
phore-labeled WT Kv4.3 (D) was expressed in the plasma membrane (E), colocalizing with DsRed-labeled membrane protein
P0 (F). The spatial profile of fluorescent intensity of WT Kv4.3 (green) and P0 (red) along the arrow imposed on the images is
shown in (G). The x-axis displays the distance relative to the start point of the arrow, and the y-axis displays the fluorescence
intensity. F227del Kv4.3 (H) was deficient in targeting to the plasma membrane (I, J). The spatial profile of fluorescent inten-
sity of F227del Kv4.3 (green) and P0 (red) along the arrow imposed on the images is shown in (K). Instead, F227del Kv4.3 was
retained in the cytoplasm (L) and colocalized with an endoplasmic reticulum-specific marker (M, N). The ratio of cell surface
expression for the p.F227del Kv4.3 was significantly lower (O) than that observed in the WT Kv4.3 (mean 6 standard error of
the mean, p.F227del: 0.28 6 0.04, n 5 10; WT Kv4.3: 0.61 6 0.06, n 5 10; p 5 0.0014, paired t test). Scale bar 5 10lm.
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NM_004980) is the third voltage-gated potassium chan-
nel gene discovered to cause human cerebellar ataxia.
Point mutations28–33 in Shaker Kv1.1-encoding KCNA1
cause episodic ataxia type 1 (OMIM160120). Point
mutations in Shaw-related Kv3.3-encoding KCNC3 cause
SCA13 (OMIM605259), with phenotypes ranging from
neurodevelopmental disorders to adult onset neurodegen-
eration.34,35 Although the exact mechanism is not yet
known how mutations may disrupt Kv4.3 function in
regulating neuronal excitability and how this may in turn
lead to neurodegeneration, the discovery of KCND3 as
the causative gene in SCA19/22 adds to the growing evi-
dence of the importance of fine tuning neuronal excit-
ability in the health and survival of neurons and espe-
cially cerebellar neurons. Other voltage-gated Kþ
channels have been proposed in neurodegenerative dis-
eases.36–38
Patients with p.F227del in Kv4.3 all have a pro-
tracted clinical course, with slowly progressive cerebellar
ataxia. As proposed, the phenotypes of dominant cerebel-
lar ataxias due to mutations other than polyglutamine
expansions are slow and less complicated despite earlier
age at onset.4 There are clinical differences between fami-
lies A and B. The Chinese family presents with relatively
pure cerebellar signs, which are consistent with the clini-
cal classification of autosomal dominant cerebellar ataxia
(ADCA) type III,39 similar to SCA6, whereas the French
family presents with signs consistent with ADCA type
I.39 The clinical progression of SCA22 appears even
slower than that of SCA6, as evaluated with the clinical
rating scale of ataxia SARA.9 For individuals carrying the
p.F227del mutation, the onset of ataxia was earlier (15–
30 years) in the younger generation than in the older
(30–50 years), which is also true for those with the
p.G345V mutation, although the age at onset was later
(50s in the older generation, compared to 30s–40s in the
younger generation), suggesting that the G345V-associ-
ated phenotype may be milder. Of note, the disease is
almost fully penetrant in the 6 families described in this
report. It is our hope and expectation that additional
patients and families will be identified with SCA19/22 to
further define the clinical features.
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